- Home
- THCH vs IVVD Comparison
THCH vs IVVD Comparison
Compare THCH & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- IVVD
- Stock Information
- Founded
- THCH 2018
- IVVD 2020
- Country
- THCH China
- IVVD United States
- Employees
- THCH N/A
- IVVD N/A
- Industry
- THCH Blank Checks
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- IVVD Health Care
- Exchange
- THCH Nasdaq
- IVVD Nasdaq
- Market Cap
- THCH 141.1M
- IVVD 123.8M
- IPO Year
- THCH N/A
- IVVD 2021
- Fundamental
- Price
- THCH $2.99
- IVVD $0.54
- Analyst Decision
- THCH
- IVVD Strong Buy
- Analyst Count
- THCH 0
- IVVD 4
- Target Price
- THCH N/A
- IVVD $7.89
- AVG Volume (30 Days)
- THCH 15.6K
- IVVD 2.1M
- Earning Date
- THCH 04-17-2025
- IVVD 03-20-2025
- Dividend Yield
- THCH N/A
- IVVD N/A
- EPS Growth
- THCH N/A
- IVVD N/A
- EPS
- THCH N/A
- IVVD N/A
- Revenue
- THCH $207,029,179.00
- IVVD $25,384,000.00
- Revenue This Year
- THCH N/A
- IVVD $606.63
- Revenue Next Year
- THCH N/A
- IVVD $120.93
- P/E Ratio
- THCH N/A
- IVVD N/A
- Revenue Growth
- THCH N/A
- IVVD N/A
- 52 Week Low
- THCH $2.78
- IVVD $0.36
- 52 Week High
- THCH $7.20
- IVVD $4.24
- Technical
- Relative Strength Index (RSI)
- THCH 45.66
- IVVD 33.07
- Support Level
- THCH $2.84
- IVVD $0.58
- Resistance Level
- THCH $3.05
- IVVD $0.68
- Average True Range (ATR)
- THCH 0.21
- IVVD 0.09
- MACD
- THCH -0.01
- IVVD -0.02
- Stochastic Oscillator
- THCH 29.17
- IVVD 0.00
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.